Metformin role in Parkinson's disease: a double-sword effect
Parkinson's disease (PD) is a common neurodegenerative disease developed due to the
degeneration of dopaminergic neurons in the substantia nigra. There is no single effective …
degeneration of dopaminergic neurons in the substantia nigra. There is no single effective …
Theophylline: Old drug in a new light, application in COVID-19 through computational studies
LM Montaño, B Sommer, JC Gomez-Verjan… - International Journal of …, 2022 - mdpi.com
Theophylline (3-methyxanthine) is a historically prominent drug used to treat respiratory
diseases, alone or in combination with other drugs. The rapid onset of the COVID-19 …
diseases, alone or in combination with other drugs. The rapid onset of the COVID-19 …
Significant impact of time-of-day variation on metformin pharmacokinetics
Aims/hypothesis The objective was to investigate if metformin pharmacokinetics is
modulated by time-of-day in humans using empirical and mechanistic pharmacokinetic …
modulated by time-of-day in humans using empirical and mechanistic pharmacokinetic …
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
The advancement in the processing speeds of computing machines has facilitated the
development of complex physiologically based pharmacokinetic (PBPK) models. These …
development of complex physiologically based pharmacokinetic (PBPK) models. These …
Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues
DM Zake, J Kurlovics, L Zaharenko, V Komasilovs… - PLoS …, 2021 - journals.plos.org
Metformin is the primary drug for type 2 diabetes treatment and a promising candidate for
other disease treatment. It has significant deviations between individuals in therapy …
other disease treatment. It has significant deviations between individuals in therapy …
Renal Transporter‐Mediated Drug‐Biomarker Interactions of the Endogenous Substrates Creatinine and N1‐Methylnicotinamide: A PBPK Modeling Approach
Endogenous biomarkers for transporter‐mediated drug‐drug interaction (DDI) predictions
represent a promising approach to facilitate and improve conventional DDI investigations in …
represent a promising approach to facilitate and improve conventional DDI investigations in …
Physiologically‐based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups
This study provides a whole‐body physiologically‐based pharmacokinetic (PBPK) model of
dextromethorphan and its metabolites dextrorphan and dextrorphan O‐glucuronide for …
dextromethorphan and its metabolites dextrorphan and dextrorphan O‐glucuronide for …
Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the …
N Nauwelaerts, J Macente, N Deferm, RH Bonan… - Pharmaceutics, 2023 - mdpi.com
Women commonly take medication during lactation. Currently, there is little information
about the exposure-related safety of maternal medicines for breastfed infants. The aim was …
about the exposure-related safety of maternal medicines for breastfed infants. The aim was …
Integrated or independent actions of metformin in target tissues underlying its current use and new possible applications in the endocrine and metabolic disorder area
G Tulipano - International journal of molecular sciences, 2021 - mdpi.com
Metformin is considered the first-choice drug for type 2 diabetes treatment. Actually,
pleiotropic effects of metformin have been recognized, and there is evidence that this drug …
pleiotropic effects of metformin have been recognized, and there is evidence that this drug …
Meta-assessment of metformin absorption and disposition pharmacokinetics in nine species
YS Jeong, WJ Jusko - Pharmaceuticals, 2021 - mdpi.com
The objective of this study was to systematically assess literature datasets and quantitatively
analyze metformin PK in plasma and some tissues of nine species. The pharmacokinetic …
analyze metformin PK in plasma and some tissues of nine species. The pharmacokinetic …